1. Home
  2. GNLX vs ELVA Comparison

GNLX vs ELVA Comparison

Compare GNLX & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • ELVA
  • Stock Information
  • Founded
  • GNLX 2001
  • ELVA 1996
  • Country
  • GNLX United States
  • ELVA Canada
  • Employees
  • GNLX N/A
  • ELVA N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • ELVA
  • Sector
  • GNLX Health Care
  • ELVA
  • Exchange
  • GNLX Nasdaq
  • ELVA Nasdaq
  • Market Cap
  • GNLX 128.0M
  • ELVA 125.5M
  • IPO Year
  • GNLX 2023
  • ELVA N/A
  • Fundamental
  • Price
  • GNLX $5.31
  • ELVA $6.42
  • Analyst Decision
  • GNLX Strong Buy
  • ELVA Strong Buy
  • Analyst Count
  • GNLX 4
  • ELVA 3
  • Target Price
  • GNLX $17.75
  • ELVA $6.50
  • AVG Volume (30 Days)
  • GNLX 134.5K
  • ELVA 512.5K
  • Earning Date
  • GNLX 11-13-2025
  • ELVA 08-13-2025
  • Dividend Yield
  • GNLX N/A
  • ELVA N/A
  • EPS Growth
  • GNLX N/A
  • ELVA 58.59
  • EPS
  • GNLX N/A
  • ELVA 0.03
  • Revenue
  • GNLX N/A
  • ELVA $54,875,000.00
  • Revenue This Year
  • GNLX N/A
  • ELVA $46.40
  • Revenue Next Year
  • GNLX N/A
  • ELVA $46.08
  • P/E Ratio
  • GNLX N/A
  • ELVA $241.02
  • Revenue Growth
  • GNLX N/A
  • ELVA 10.88
  • 52 Week Low
  • GNLX $1.99
  • ELVA $1.73
  • 52 Week High
  • GNLX $5.89
  • ELVA $7.49
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 79.41
  • ELVA 54.41
  • Support Level
  • GNLX $4.17
  • ELVA $5.75
  • Resistance Level
  • GNLX $4.83
  • ELVA $6.91
  • Average True Range (ATR)
  • GNLX 0.29
  • ELVA 0.40
  • MACD
  • GNLX 0.07
  • ELVA -0.05
  • Stochastic Oscillator
  • GNLX 95.62
  • ELVA 41.09

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About ELVA Electrovaya Inc.

Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.

Share on Social Networks: